key: cord-0833137-pbcnufpf authors: Elshafeey, Farida; Magdi, Rana; Hindi, Nader; Elshebiny, Mohamed; Farrag, Nourhan; Mahdy, Shahd; Sabbour, Mohamed; Gebril, Sara; Nasser, Mohamed; Kamel, Menna; Amir, Abdelrahman; Maher Emara, Moataz; Nabhan, Ashraf title: A systematic scoping review of COVID‐19 during pregnancy and childbirth date: 2020-05-17 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13182 sha: be0e3db8ec23e12548ea11de5a124ff81c465ddd doc_id: 833137 cord_uid: pbcnufpf BACKGROUND: Clinical presentation and outcomes of COVID‐19 infection during pregnancy remain limited and fragmented. OBJECTIVES: To summarize the existing literature on COVID‐19 infection during pregnancy and childbirth, particularly concerning clinical presentation and outcomes. SEARCH STRATEGY: A systematic search of LitCovid, EBSCO MEDLINE, CENTRAL, CINAHL, Web of Science, and Scopus electronic databases. The references of relevant studies were also searched. SELECTION CRITERIA: Identified titles and abstracts were screened to select original reports and cross‐checked for overlap of cases. DATA COLLECTION AND ANALYSIS: A descriptive summary organized by aspects of clinical presentations (symptoms, imaging, and laboratory) and outcomes (maternal and perinatal). MAIN RESULTS: We identified 33 studies reporting 385 pregnant women with COVID‐19 infection: 368 (95.6%) mild; 14 (3.6%) severe; and 3 (0.8%) critical. Seventeen women were admitted to intensive care, including six who were mechanically ventilated and one maternal mortality. A total of 252 women gave birth, comprising 175 (69.4%) cesarean and 77 (30.6%) vaginal births. Outcomes for 256 newborns included four RT‐PCR positive neonates, two stillbirths, and one neonatal death. CONCLUSION: COVID‐19 infection during pregnancy probably has a clinical presentation and severity resembling that in non‐pregnant adults. It is probably not associated with poor maternal or perinatal outcomes. COVID-19 is caused by a virus that belongs to the coronaviruses, which are positive-sense, single-stranded RNA viruses. Coronaviruses contain the largest genomes of all RNA viruses. They have helical nucleocapsids and an envelope that is derived from intracellular membranes. Electron micrographs show spikes sticking out of their surfaces (due to a large glycoprotein), leading to their name (corona=crown). Seven coronaviruses cause human disease, of which three are highly pathogenic: SARS-CoV, MERS-CoV, and the new SARS-COV-2, which causes COVID-19. Phylogenic analysis and genome sequencing identified SARS-COV-2 as a member of the subgenus Sarbecovirus (beta-CoV lineage B), similar to the severe acute respiratory syndrome (SARS) virus, but in a different clade. 1 The spectrum of symptomatic infection ranges from mild to critical. In a report that included approximately 44 672 confirmed infections, the severity was mild (no or mild pneumonia) in 81%; severe (e.g. with more than 50% lung involvement on imaging within 24-48 hours) in 14%; or critical (e.g. with respiratory failure or multiorgan dysfunction) in 5%. The overall case fatality rate was 2.3%. 2 Viral pandemics threaten the general population including pregnant women. The generalization of pregnancy as a condition of immune suppression or increased risk of infection represents a misleading concept. Pregnancy represents a unique immune condition that is modulated, but not suppressed. The correct concept would allow caregivers and policy makers to make valid recommendations for treating pregnant women during pandemics. 3 In this critical time of a COVID-19 pandemic, caregivers need to understand the spectrum of presentations and outcomes of COVID-19 infection during pregnancy and childbirth. Therefore, the aim of the present scoping review was to systematically map the state of knowledge of COVID-19 infection during pregnancy, particularly as it pertains to clinical presentation and outcomes. We conducted a systematic search using the LitCovid, EBSCO MEDLINE, CENTRAL, CINAHL, Web of Science, and Scopus electronic databases. The search was last updated on April 19, 2020. We did not impose any language restriction. The detailed search strategy can be found in Data S1. Following study selection (stage 3), we searched the list of references in the selected studies. We contacted the authors of published reports for additional information. Two authors (RM and FE) independently screened citation titles and abstracts, then reviewed potentially relevant articles in full. We considered any article reporting original research of COVID-19 during pregnancy, whether diagnosis was confirmed by reverse-transcription polymerase chain reaction (RT-PCR) or based on clinical, imaging, and laboratory criteria. If agreement on abstract or full article inclusion could not be reached between the two reviewers, an opinion was requested from a third reviewer (AN). A data-charting electronic form was jointly developed by two reviewers (NH and ME) to determine which variables to extract. Two authors (NF and MS) independently extracted data and (SM, MN, AA, MK and MME) continuously updated the data-charting form. We extracted the following data items: general data (title, year of publication, author's name, country); methodological data (research design, setting, sample, participant characteristics-e.g. age, gestational age at diagnosis); and clinical data (clinical presentation, illness severity, gestational age at delivery, mode of delivery, mode of analgesia or anesthesia, maternal outcomes, perinatal outcomes). We did not perform a formal critical appraisal of primary studies for this scoping review. The results were organized under the following categories: clinical presentation, maternal outcomes, and perinatal outcomes. We reported the review following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelinesextension for scoping review. 5 We identified 33 original studies reporting 385 women with COVID-19 during pregnancy and childbirth. Figure 1 shows the process of study inclusion in the scoping review. The studies included one case-control study from China, 6 16 case reports (from Australia, 7 China, [8] [9] [10] [11] [12] [13] [14] [15] [16] Honduras, 17 Iran, 18 South Korea, 19 Sweden, 20 Turkey, 21 and the USA 22 ), and 16 case series (from China, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Italy, 35 The Netherlands, 36 and the USA 37,38 ). We mapped the distribution of studies according to the study design ( Table 1 ). The studies reported data between December 8, 2019 and April 19, 2020. Maternal age of the reported cases ranged from 21-42 years. Infection was asymptomatic in 29 (7.5%) women. Symptoms at the time of diagnosis were reported in most women (n=356, 92.5%). The most frequent symptoms were fever (n=259, 67.3%); cough (n=253, 65.7%); dyspnea (n=28, 7.3%); diarrhea (n=28, 7.3%); sore throat (n=27, 7.0%); fatigue (n=27, 7.0%); myalgia (n=24, 6.2%); and chills (n=21, 5.5%). Other symptoms were reported in less than 5% of women and included nasal congestion, rash, sputum production, headache, malaise, and loss of appetite. women. Twelve of the continuous epidural cases experienced hypotension (<30% of basal) that was managed intraoperatively. Case severity was mild in 368 (95.6%) women, severe in 14 (3.6%), and critical in 3 (0.8%). The critical cases had multiple organ dysfunction syndrome (MODS) including acute respiratory distress syndrome (ARDS). Seventeen (4.4%) women required admission to an intensive care unit (ICU) and 6 (1.6%) were mechanically ventilated, including one on extracorporeal membrane oxygenation (ECMO). All ICU admissions improved and were discharged, except for one mortality and one case on ECMO. On April 6, 2020 we contacted the authors of the cases series that included the case on ECMO for an update on her outcome. We did not receive the required data. mortality. 39 Pregnancy modulates the immune system. Human chorionic gonadotropin and progesterone inhibit the Th1 proinflammatory pathway via decreasing tumor necrosis factor-α. 3 We speculate that this modulated immune system might protect pregnant women from the cytokine storm syndrome and associated morbidity and mortality. This might explain the results of reported outcomes among the 385 women in 33 reports. We extracted data regarding potential vertical transmission. In four neonates who had RT-PCR confirmed infection, samples from T A B L E 1 Distribution of study designs included in the review. Case-control China 1 16 Case should work to create a responsive data collection system to ensure a rapid assessment of the risks linked to future emergent pathogens. The development of and adherence to a set of core outcomes for reporting studies of COVID-19 during pregnancy is essential. Finally, we believe that the inclusion of pregnant women in current trials may be considered. Our scoping review has some limitations. To make our review feasible, we were only able to include data from published or shared individual patient data. We believe that, amid a critical time of a pandemic, cases of COVID-19 during pregnancy may not have been shared by every healthcare facility. This is a rapidly evolving healthcare issue. This scoping review was an enormous undertaking and our results are only up to date to April 20, 2020. We did not assess the quality of reports. We understand that during a pandemic, the intention to share data rapidly might have an impact on the quality of published primary reports. Some of the primary sources might overlap. We have traced the cases through careful data collection and contacting the authors to minimize the possibility of double counting. In conclusion, the currently available data suggest that COVID-19 infection during pregnancy has a similar clinical presentation and illness severity to non-pregnant adults and may not be associated with poor maternal or perinatal outcomes. All authors made substantive intellectual contributions to the development of this manuscript. AN contributed to the study conception and design and conceptualized the review approach. NH, FE, RM, MS, MN, NF, ME, SM, MK, AA, SG, and MME contributed to the screening, study selection, data charting, and data extraction. AN led the manuscript writing. All authors provided detailed comments on earlier drafts and approved the final manuscript. We thank Mr Tianxiao Xu for his assistance with the translation of the Chinese papers. We are grateful to Professor Hassan Awwad, Chairman of the Department of Obstetrics and Gynecology at Ain Shams University for his guidance and support. The authors have no conflicts of interest. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China The immune system in pregnancy: A unique complexity Scoping studies: Towards a methodological framework PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: A case-control study COVID-19 vaginal delivery -a case report Asymptomatic COVID-19 in pregnant woman with typical chest CT manifestation: A case report Asymptomatic COVID-19 infection in pregnant woman in the third trimester: A case report Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID 19 A patient with SARS-CoV-2 infection during pregnancy in Qingdao Chest CT findings in a pregnant patient with 2019 Novel Coronavirus disease Lack of vertical transmission of severe acute respiratory syndrome Coronavirus 2, China. Emerg Infect Dis Anesthesia management in cesarean section for a patient with coronavirus disease Zhejiang Da Xue Xue Bao Yi Xue Ban Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery A pregnant woman with COVID-19 in Central America Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed patient COVID-19 in pregnancy with comorbidities: More liberal testing strategy is needed Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 An uncomplicated delivery in a patient with Covid-19 in the United States Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: A case series of 17 patients Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth Clinical characteristics of COVID-19 in pregnancy: Analysis of nine cases Pregnancy and perinatal outcomes of women with Coronavirus disease (COVID-19) pneumonia: A preliminary analysis Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study Antibodies in Infants Born to Mothers With COVID-19 Pneumonia Executive management summary and short report of outcome Update registration COVID-19 positive pregnant women in NethOSS COVID-19 in pregnancy: Early lessons Two cases of COVID-19 related cardiomyopathy in pregnancy COVID-19: Consider cytokine storm syndromes and immunosuppression